TAG:
cap
DIANON Shoots At Urocor, Makes Unwelcome Offer
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
CEO SUMMARY: It pays to know your friends. Last month DIANON Systems announced an unsolicited offer to acquire UroCor. The offer, following months of ongoing discussions between the two companies, was clearly unwelcome at UroCor. Both companies are pushing hard to evolve disease managemen…
Veterans Administration Network Restructures Using Partnering, Telepathology
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
CEO SUMMARY: Economic pressures are forcing even the traditional and staid Veterans Administration to extensively reconfigure its laboratory services. At this year’s Executive War College in New Orleans, participants learned how one eight-hospi…
Problems In PPM lndustry Affect Pathology Practices
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
DURING 1998, THE FINANCIAL WOES of many physician practice management (PPM) companies caught healthcare experts, investors, and financial experts by surprise. Problems with the PPM industry could not come at a worse time for the pathology profession. At the very moment that several pathology-based P…
September 8, 1998 Intelligence: Late Breaking Lab News
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
If any one individual was to be credited with creating the modern commercial laboratory organization, it would be Paul Brown, M.D., founder and former Chairman of MetPath, Inc. (now Quest Diagnostics Incorporated). Where is he now? For ten years, he served as a Direc…
Doom And Gloom Versus Optimism
By R. Lewis Dark | From the Volume V No. 11 – August 17, 1998 Issue
COUNT ME AS ONE WHO IS NOT SURPRISED THAT SEVERAL of healthcare’s billion-dollar corporations have posted huge losses. I may be at the age of retirement, and I might be guilty of values and ethics often labeled as “old fashioned,” but I am possessed with common sense. Those of our clients care…
United Health’s Big Losses Derail Merger With Humana
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: Considered the darling of the managed care industry by investors, United Healthcare’s huge write-down makes it the latest healthcare behemoth to post an immense loss. Laboratory executives should see this as a sign that even big healthcare companies are struggling to develop fiscal sta…
“Corporatized” Healthcare Encountering Big Losses
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: When the clinical laboratory industry found itself losing hundreds of millions of dollars in recent years, few people imagined that billion-dollar HMO and PPM companies would soon experience similar losses. Current trends in the managed care marketplace indicate that problems…
AACC Convention Exhibits Point To New Lab Trends
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: This year the interesting trend at the AACC’s exhibit hall was modular laboratory automation. That’s a big change from the total laboratory automation solutions touted in past years. But watch out! The economics of this equipment have yet to be validated. It was also clea…
Blunt Talk From HMO Blue’s Ancillary Contracts Manager
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: By now, most clinical laboratory executives and pathologists have discovered a new fact of life: provider status with managed care organizations is a critical success factor. Without provider status, the laboratory is denied access to patients and the reimbursement associated…
AccuMed, AutoCyte, Cytyc, MorphoMetrix, Neuromedical, NeoPath
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
Automated Cytology Update As predicted by THE DARK REPORT, the field of automated cytology has become a boiling pot, filled with controversy and change. Profits are meager. As we expected, the major issue revolves around the cost of this enhanced technology versus the measurable…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized